{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:24:53Z","timestamp":1754112293812,"version":"3.37.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Azole resistance in Aspergillus fumigatus is increasing worldwide and can affect prognosis. It is mostly mediated by cytochrome P51 (CYP51) mutations. In lung transplant recipients (LTR), little is known regarding the prevalence and clinical impact of CYP51 mutations. One hundred thirty-one consecutive A. fumigatus isolates from 103 patients were subjected to CYP51A genotyping through PCR and sequencing. Antifungal susceptibility testing was performed using the Sensititre YeastOne YO-9\u00a9 broth microdilution technique. Correlations between genotype, phenotype, clinical manifestations of Aspergillus infection, and clinical outcomes were made. Thirty-four (26%) isolates harbored mutations of CYP51A; N248K (n\u00a0=\u00a014) and A9T (n\u00a0=\u00a012) were the most frequent. Three isolates displayed multiple point mutations. No significant influences of mutational status were identified regarding azole MICs, the clinical presentation of Aspergillus disease, 1-year all-cause mortality, and clinical outcomes of invasive forms. In the specific context of lung transplant recipients, non-hotspot CYP51A-mutated isolates are regularly encountered; this does not result in major clinical consequences or therapeutic challenges.<\/jats:p><\/jats:sec><jats:sec><jats:title>Lay Summary<\/jats:title><jats:p>In 131 isolates of Aspergillus fumigatus isolates originating from 103 lung transplant recipients, the CYP51A polymorphism rate was 26%, mostly represented by N248K and A9T mutations. These mutations, however, did not significantly impact azoles minimal inhibitory concentrations or clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1093\/mmy\/myaa110","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:59:08Z","timestamp":1609970348000},"page":"728-733","source":"Crossref","is-referenced-by-count":6,"title":["CYP51A polymorphisms of<i>Aspergillus fumigatus<\/i>in lung transplant recipients: Prevalence, correlation with phenotype, and impact on outcomes"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-4121","authenticated-orcid":false,"given":"Beno\u00eet","family":"Henry","sequence":"first","affiliation":[{"name":"Transplant Infectious Diseases, Multi-organ Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Guenette","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-organ Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiqa","family":"Cheema","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-organ Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armelle","family":"P\u00e9rez-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-organ Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"McTaggart","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Mazzulli","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Mt. Sinai Hospital\/University Health Network, Toronto, ON, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne","family":"Singer","sequence":"additional","affiliation":[{"name":"Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-8094","authenticated-orcid":false,"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[{"name":"Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianne V","family":"Kus","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, ON, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-organ Transplant Program, University Health Network, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"2021070523531754800_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis."},{"key":"2021070523531754800_bib2","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.ijantimicag.2019.09.011","article-title":"Azole resistance mechanisms in Aspergillus: update and recent advances","volume":"55","author":"P\u00e9rez-Cantero","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"2021070523531754800_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"2021070523531754800_bib4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive Aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis."},{"key":"2021070523531754800_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerging Infect Dis."},{"key":"2021070523531754800_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid2607.200088","article-title":"Paradoxal trends in azole-resistant Aspergillus fumigatus in a national multicenter surveillance program, the Netherlands, 2013\u20132018","volume":"26","author":"Lestrade","year":"2020","journal-title":"Emerging Infect Dis."},{"key":"2021070523531754800_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkq450","article-title":"Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies","volume":"66","author":"Alanio","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"2021070523531754800_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/jac\/dkx527","article-title":"Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study","volume":"73","author":"Lestrade","year":"2018","journal-title":"J Antimicrob Chemother."},{"key":"2021070523531754800_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/myc.13139","article-title":"High prevalence of triazole-resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis","volume":"63","author":"Brito Devoto","year":"2020","journal-title":"Mycoses"},{"key":"2021070523531754800_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jcf.2018.11.012","article-title":"Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study","volume":"18","author":"Engel","year":"2019","journal-title":"J Cyst Fibros."},{"key":"2021070523531754800_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24 Suppl 1","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"2021070523531754800_bib12","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.15585\/mmwr.mm6738a5","article-title":"Multidrug-resistant aspergillus fumigatus carrying mutations linked to environmental fungicide exposure - three states, 2010\u20132017","volume":"67","author":"Beer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2021070523531754800_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12516","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis","volume":"29","author":"Chong","year":"2015","journal-title":"Clin Transplant."},{"key":"2021070523531754800_bib14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/jac\/dku528","article-title":"Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis","volume":"70","author":"Shalhoub","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"2021070523531754800_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/AAC.01130-15","article-title":"Molecular characterization of a voriconazole-resistant, posaconazole-susceptible aspergillus fumigatus isolate in a lung transplant recipient in the United States","volume":"60","author":"Vazquez","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","year":"2017","author":"Alexander","key":"2021070523531754800_bib16"},{"key":"2021070523531754800_bib17","volume-title":"Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi","author":"Clinical and Laboratory Standards Institute","year":"2020","edition":"2nd ed"},{"key":"2021070523531754800_bib18","doi-asserted-by":"crossref","first-page":"e01651","DOI":"10.1128\/AAC.01651-18","article-title":"Method-dependent epidemiological cutoff values for detection of triazole resistance in candida and aspergillus species for the sensititre yeastone colorimetric broth and etest agar diffusion methods","volume":"63","author":"Espinel-Ingroff","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant."},{"key":"2021070523531754800_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and european organization for research and treatment of cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis."},{"key":"2021070523531754800_bib21","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3201\/eid2509.190598","article-title":"Invasive fungal disease, isavuconazole treatment failure, and death in acute myeloid leukemia patients","volume":"25","author":"Bellanger","year":"2019","journal-title":"Emerging Infect Dis."},{"key":"2021070523531754800_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11046-018-0271-8","article-title":"TR34\/L98H mutation in CYP51A gene in aspergillus fumigatus clinical isolates during posaconazole prophylaxis: first case in Korea","volume":"183","author":"Lee","year":"2018","journal-title":"Mycopathologia."},{"key":"2021070523531754800_bib23","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"2021070523531754800_bib24","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.01544-10","article-title":"Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole","volume":"55","author":"Kuipers","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib25","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/ajt.14940","article-title":"Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis","volume":"18","author":"Pilmis","year":"2018","journal-title":"Am J Transplant."},{"key":"2021070523531754800_bib26","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/AAC.02855-14","article-title":"First detection of TR46\/Y121F\/T289A and TR34\/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment","volume":"58","author":"Astvad","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"article-title":"Analysis of cyp51A polymorphisms of Aspergillus fumigatus in Japan","year":"2020","author":"Majima","key":"2021070523531754800_bib27"},{"key":"2021070523531754800_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib29","doi-asserted-by":"crossref","first-page":"e02240","DOI":"10.1128\/AAC.02240-17","article-title":"Detection of TR34\/L98H CYP51A mutation through passive surveillance for azole-resistant aspergillus fumigatus in the United States from 2015 to 2017","volume":"62","author":"Berkow","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3201\/eid2009.140142","article-title":"Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011\u20132013","volume":"20","author":"Pham","year":"2014","journal-title":"Emerging Infect Dis."},{"key":"2021070523531754800_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1462-2920.13988","article-title":"Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan","volume":"20","author":"Wang","year":"2018","journal-title":"Environ Microbiol."},{"key":"2021070523531754800_bib32","first-page":"e00536","article-title":"Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing","volume":"6","author":"Abdolrasouli","year":"2015","journal-title":"mBio"},{"key":"2021070523531754800_bib33","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/AAC.05990-11","article-title":"Azole preexposure affects the Aspergillus fumigatus population in patients","volume":"56","author":"Alanio","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib34","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.01358-10","article-title":"Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole","volume":"55","author":"Escribano","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib35","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00127-15","article-title":"First description of azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation in France","volume":"59","author":"Lavergne","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib36","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"2021070523531754800_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jac\/dks451","article-title":"High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates","volume":"68","author":"Buied","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"2021070523531754800_bib38","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerging Infect Dis."},{"key":"2021070523531754800_bib39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/mmy\/myw005","article-title":"Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance","volume":"54","author":"Meneau","year":"2016","journal-title":"Med Mycol."},{"key":"2021070523531754800_bib40","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/mmy\/myx144","article-title":"Triazole resistance surveillance in Aspergillus fumigatus","volume":"56","author":"Resendiz Sharpe","year":"2018","journal-title":"Med Mycol."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/7\/728\/38670790\/myaa110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/7\/728\/38670790\/myaa110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T20:38:05Z","timestamp":1670704685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/7\/728\/6071838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,1,8]]},"published-print":{"date-parts":[[2021,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaa110","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"type":"print","value":"1369-3786"},{"type":"electronic","value":"1460-2709"}],"subject":[],"published-other":{"date-parts":[[2021,7]]},"published":{"date-parts":[[2021,1,8]]}}}